Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by FSM Wealth Advisors LLC

FSM Wealth Advisors LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 526 shares of the medical equipment provider’s stock after buying an additional 19 shares during the quarter. FSM Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $275,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $26,000. Godsey & Gibb Inc. increased its stake in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical in the 3rd quarter valued at approximately $33,000. Decker Retirement Planning Inc. purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new position in Intuitive Surgical in the 3rd quarter valued at approximately $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $571.88 on Monday. The stock has a market cap of $203.69 billion, a price-to-earnings ratio of 89.22, a PEG ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm’s 50-day moving average is $550.40 and its 200-day moving average is $509.43.

Insider Buying and Selling

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 28,843 shares of company stock worth $15,357,560. Corporate insiders own 0.80% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on ISRG shares. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. BTIG Research raised their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. CICC Research initiated coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target for the company. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, UBS Group raised their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.